Pub. Date : 2008 Feb
PMID : 17597710
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | In CYP2C9*3 allele carriers using tolbutamide, the prescribed dose was lower compared to patients with the wild-type CYP2C9 genotype. | Tolbutamide | cytochrome P450 family 2 subfamily C member 9 | Homo sapiens |
2 | In CYP2C9*3 allele carriers using tolbutamide, the prescribed dose was lower compared to patients with the wild-type CYP2C9 genotype. | Tolbutamide | cytochrome P450 family 2 subfamily C member 9 | Homo sapiens |
3 | In CYP2C9*3 allele carriers, the mean decrease in fasting serum glucose levels after the start of tolbutamide therapy was larger than in patients with the wild-type genotype, although not statistically significant. | Tolbutamide | cytochrome P450 family 2 subfamily C member 9 | Homo sapiens |
4 | Patients with diabetes mellitus who are carriers of a CYP2C9*3 allele require lower doses of tolbutamide to regulate their serum glucose levels compared to patients with the wild-type genotype. | Tolbutamide | cytochrome P450 family 2 subfamily C member 9 | Homo sapiens |